Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 216
Filtrar
1.
Artículo en Inglés | MEDLINE | ID: mdl-14623497

RESUMEN

Findings to date provide evidence that altered membrane structure and function are present in patients with either first-episode or chronic schizophrenia, suggesting defects in phospholipid metabolism and cell signaling in schizophrenia. The purpose of this investigation is to test whether decreased membrane polyunsaturated fatty acids (PUFAs) were associated with an increased secretion of proinflammatory cytokines. Thus, we measured interleukin 6 (IL-6) and interleukin 10 (IL-10) in cerebrospinal fluid (CSF) of patients with chronic schizophrenia as well as PUFAs of red blood cell (RBC) membranes from the same individuals. A significant and inverse correlation was found between CSF IL-6 (not IL-10) and RBC membrane PUFAs levels in both haloperidol-treated and medication-free patients with schizophrenia. Specifically, such an association was found in the n-6 (18:2, 20:4, and 22:4) and, to a lesser extent, the n-3 fatty acids. Taken together, the present findings suggest that decreased membrane PUFAs may be related to an immune disturbance in schizophrenia, possibly resulting from an increased phospholipase A2 activity mediated through the proinflammatory cytokines.


Asunto(s)
Citocinas/metabolismo , Membrana Eritrocítica/metabolismo , Ácidos Grasos Insaturados/metabolismo , Esquizofrenia/metabolismo , Cromatografía de Gases/métodos , Citocinas/sangre , Citocinas/líquido cefalorraquídeo , Ensayo de Inmunoadsorción Enzimática , Ácidos Grasos Insaturados/sangre , Ácidos Grasos Insaturados/líquido cefalorraquídeo , Haloperidol/administración & dosificación , Humanos , Interleucina-10/sangre , Interleucina-10/líquido cefalorraquídeo , Interleucina-6/sangre , Interleucina-6/líquido cefalorraquídeo , Masculino , Esquizofrenia/sangre , Esquizofrenia/líquido cefalorraquídeo
2.
Exp Neurol ; 172(1): 29-46, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11681838

RESUMEN

The neural cell adhesion molecule (N-CAM) is a cell recognition molecule involved in cellular migration, synaptic plasticity, and CNS development. A 105- to 115-kDa isoform of N-CAM (cleaved N-CAM or cN-CAM) is increased in schizophrenia in hippocampus, prefrontal cortex, and CSF. We purified and partially characterized cN-CAM, a putative novel isoform, and confirmed that the first 9 amino acids were identical to exon 1 of N-CAM, without the signal sequence. Analysis of trypsin-digested cN-CAM fragments by matrix-assisted laser desorption ionization on a time-of-flight mass spectrometer (MALDI-TOF) yielded peptides that could be identified as being derived from the first 548 amino acid residues of the expected N-CAM amino acid sequence. Immunological identification with four specific N-CAM antisera directed toward cytoplasmic, secreted, variable alternative spliced exon, or GPI epitopes failed to indicate other known splice variants. Neuraminidase treatment of cN-CAM produced a minor alteration resulting in a faster migrating immunoreactive band, indicating partial glycosylation of cN-CAM. Membranous particles from cytosolic brain extract containing cN-CAM were obtained by ultracentrifugation; however, CSF contained few such particles. cN-CAM and synaptophysin were colocalized on these particles. Both cN-CAM and N-CAM 180 were present in synaptosomal preparations of human brain. Following incubation of synaptosomes or brain tissue without protease inhibitors, N-CAM 180 was degraded and cN-CAM was increased. A cN-CAM-like band was present in human fetal neuronal cultures, but not in fetal astrocyte cultures. Thus, cN-CAM represents a protease- and neuraminidase-susceptible fragment possibly derived by proteolytic cleavage of N-CAM 180. An enlargement in ventricular volume in a group of adult patients with schizophrenia over a 2-year interval was found to be correlated with CSF cN-CAM levels as measured at the time of the initial MRI scan (r = 0.53, P = 0.01). cN-CAM is associated with ventricular enlargement; thus, the release of N-CAM fragments may be part of the pathogenic mechanism of schizophrenia in vulnerable brain regions such as the hippocampus and prefrontal cortex. Alternatively, the increases in cN-CAM in schizophrenia may be a reflection of a more general abnormality in the regulation of proteolysis or of extracellular matrix stability.


Asunto(s)
Moléculas de Adhesión de Célula Nerviosa/química , Moléculas de Adhesión de Célula Nerviosa/metabolismo , Esquizofrenia/metabolismo , Adulto , Empalme Alternativo , Encéfalo/metabolismo , Células Cultivadas , Líquido Cefalorraquídeo/química , Epítopos/metabolismo , Femenino , Glicosilación , Humanos , Sueros Inmunes/metabolismo , Masculino , Moléculas de Adhesión de Célula Nerviosa/genética , Neuraminidasa/metabolismo , Fragmentos de Péptidos/química , Isoformas de Proteínas/química , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Análisis de Secuencia de Proteína , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Fracciones Subcelulares/química , Sinaptosomas/química , Sinaptosomas/metabolismo , Tripsina/metabolismo
3.
Schizophr Bull ; 27(3): 503-15, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11596851

RESUMEN

Effects of fluphenazine on electrodermal activity (EDA) and heart rate (HR) were studied in patients with schizophrenia and normal control subjects during rest periods, presentation of innocuous tones, and a reaction time (RT) task. Two types of analyses were used: (1) between-group analyses-patients taking placebo were compared with patients taking fluphenazine and with control subjects using only data from the first test session; and (2) within-subject analyses-the same patients were tested when taking fluphenazine and when taking placebo. Results showed higher resting EDA and HR and smaller increments to task performance in placebo patients than in control subjects. Fluphenazine attenuated EDA levels but not the tonic response. Fluphenazine attenuated the HR response but did not affect HR level. Placebo patients were electrodermally hyporesponsive to the RT stimuli but not to simple tones. Fluphenazine markedly attenuated responsivity to simple tones but it attenuated responsivity less for RT stimuli. Testing medicated patients may thus produce misleading results with respect to many, but not all, purported autonomic markers of diagnosis in schizophrenia studies.


Asunto(s)
Antipsicóticos/farmacología , Antipsicóticos/uso terapéutico , Flufenazina/farmacología , Flufenazina/uso terapéutico , Frecuencia Cardíaca/efectos de los fármacos , Esquizofrenia/tratamiento farmacológico , Adulto , Antiparkinsonianos/uso terapéutico , Benzotropina/uso terapéutico , Electrocardiografía , Femenino , Flufenazina/efectos adversos , Humanos , Masculino , Trastornos Parkinsonianos/inducido químicamente , Trastornos Parkinsonianos/tratamiento farmacológico , Tiempo de Reacción/efectos de los fármacos
4.
Lancet ; 358(9282): 619-24, 2001 Aug 25.
Artículo en Inglés | MEDLINE | ID: mdl-11530148

RESUMEN

BACKGROUND: Acute respiratory infections (ARI) are the leading cause of the global burden of disease and have been causally linked with exposure to pollutants from domestic biomass fuels in less-developed countries. We used longitudinal health data coupled with detailed monitoring of personal exposure from more than 2 years of field measurements in rural Kenya to estimate the exposure-response relation for particulates smaller than 10 mm in diameter (PM(10)) generated from biomass combustion. METHODS: 55 randomly-selected households (including 93 infants and children, 229 individuals between 5 and 49 years of age, and 23 aged 50 or older) in central Kenya were followed up for more than 2 years. Longitudinal data on ARI and acute lower respiratory infections (ALRI) were recorded at weekly clinical examinations. Exposure to PM(10) was monitored by measurement of PM(10) emission concentration and time-activity budgets. FINDINGS: With the best estimate of the exposure-response relation, we found that ARI and ALRI are increasing concave functions of average daily exposure to PM(10), with the rate of increase declining for exposures above about 1000-2000 mg/m(3). After we had included high-intensity exposure episodes, sex was no longer a significant predictor of ARI and ALRI. INTERPRETATION: The benefits of reduced exposure to PM(10) are larger for average exposure less than about 1000-2000 mg/m(3). Our findings have important consequences for international public-health policies, energy and combustion research, and technology transfer efforts that affect more than 2 billion people worldwide.


Asunto(s)
Contaminantes Atmosféricos/análisis , Contaminación del Aire Interior/análisis , Monitoreo del Ambiente/métodos , Infecciones del Sistema Respiratorio/etiología , Enfermedad Aguda , Adolescente , Adulto , Contaminantes Atmosféricos/efectos adversos , Contaminación del Aire Interior/efectos adversos , Contaminación del Aire Interior/estadística & datos numéricos , Biomasa , Niño , Preescolar , Culinaria , Países en Desarrollo , Fuentes Generadoras de Energía , Monitoreo Epidemiológico , Femenino , Calefacción , Vivienda , Humanos , Lactante , Recién Nacido , Kenia/epidemiología , Análisis de los Mínimos Cuadrados , Modelos Logísticos , Masculino , Persona de Mediana Edad , Modelos Estadísticos , Salud Pública , Infecciones del Sistema Respiratorio/epidemiología
5.
CNS Drugs ; 15(4): 287-310, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11463134

RESUMEN

Free radicals are highly reactive chemical species generated during normal metabolic processes. which in excess can lead to membrane damage. Elaborate antioxidant defence systems exist to protect against oxidative stress. There is accumulating evidence of altered antioxidant capacity in schizophrenia. Membrane dysfunction can be secondary to free radical-mediated pathology, and may contribute to specific aspects of schizophrenic symptomatology and complications of its treatment. Specifically, free radical-mediated abnormalities may contribute to the development of a number of clinically significant consequences, including prominent negative symptoms, tardive dyskinesia, neurological 'soft' signs and parkinsonian symptoms. Our previous results showing altered membrane dynamics and antioxidant enzyme activities in schizophrenia, and findings from other investigators, are consistent with the notion of free radical-mediated neurotoxicity in schizophrenia. These findings provide a theoretical basis from which the development of novel therapeutic strategies such as fatty acid and antioxidant supplementation can occur in the future.


Asunto(s)
Antipsicóticos/uso terapéutico , Estrés Oxidativo , Esquizofrenia/metabolismo , Antipsicóticos/efectos adversos , Encéfalo/enzimología , Encéfalo/patología , Estructuras de la Membrana Celular/metabolismo , Discinesia Inducida por Medicamentos/etiología , Discinesia Inducida por Medicamentos/metabolismo , Radicales Libres/metabolismo , Humanos , Peroxidación de Lípido , Mitocondrias/enzimología , Mitocondrias/metabolismo , Factores de Riesgo , Esquizofrenia/terapia
6.
Environ Health Perspect ; 109(5): 481-8, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11401759

RESUMEN

Acute respiratory infections (ARI) are the leading cause of burden of disease worldwide and have been causally linked with exposure to pollutants from domestic biomass fuels in developing countries. We used longitudinal health data coupled with detailed monitoring and estimation of personal exposure from more than 2 years of field measurements in rural Kenya to estimate the exposure-response relationship for particulates < 10 microm diameter (PM(10)) generated from biomass combustion. Acute respiratory infections and acute lower respiratory infections are concave, increasing functions of average daily exposure to PM(10), with the rate of increase declining for exposures above approximately 1,000-2,000 microg/m(3). This first estimation of the exposure-response relationship for the high-exposure levels characteristic of developing countries has immediate and important consequences for international public health policies, energy and combustion research, and technology transfer efforts that affect more than 2 billion people worldwide.


Asunto(s)
Contaminantes Atmosféricos/análisis , Contaminación del Aire Interior/análisis , Países en Desarrollo , Monitoreo del Ambiente/métodos , Infecciones del Sistema Respiratorio/etiología , Enfermedad Aguda , Adolescente , Adulto , Contaminantes Atmosféricos/efectos adversos , Contaminación del Aire Interior/efectos adversos , Contaminación del Aire Interior/estadística & datos numéricos , Biomasa , Niño , Preescolar , Culinaria , Fuentes Generadoras de Energía , Monitoreo Epidemiológico , Femenino , Calefacción , Vivienda , Humanos , Lactante , Kenia , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Modelos Estadísticos , Salud Pública , Infecciones del Sistema Respiratorio/epidemiología
7.
Schizophr Bull ; 27(1): 39-46, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11215548

RESUMEN

Because schizophrenia is considered to be a neurodevelopmental disorder, premorbid adjustment is of particular interest. Premorbid adjustment is probably not a unitary construct but rather is expressed across a number of developmental domains. The current investigation examined the validity of a two-factor model that differentiated premorbid adjustment across social and academic domains and evaluated relationships between these premorbid adjustment domains and other variables of interest. Participants with schizophrenia (n = 141) underwent evaluation of premorbid adjustment (using the Premorbid Adjustment Scale), intellectual functioning, and psychiatric symptoms. Using confirmatory factor analysis, a two-factor model of premorbid adjustment was identified that included an academic domain and a social domain. The social domain was associated with symptom variables, while the academic domain was associated with measures of intelligence. Results provide evidence for at least two domains of premorbid adjustment in schizophrenia. Distinguishing between these two premorbid domains may be theoretically important because of potential differences in incidence rates and deterioration courses; some individuals with schizophrenia may exhibit adequate academic adjustment but poor social adjustment, while others may exhibit the opposite pattern.


Asunto(s)
Trastornos de Adaptación/psicología , Modelos Psicológicos , Esquizofrenia/etiología , Adulto , Humanos , Inteligencia , Masculino , Pronóstico , Escalas de Valoración Psiquiátrica , Factores de Riesgo
8.
Appl Occup Environ Hyg ; 16(11): 1035-42, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11757899

RESUMEN

This study provides a means for the evaluation of cleaner manufacturing and the provision of cost-effective worker health improvements in developing nations. Individual worker exposure to volatile organic compounds was measured in the paint manufacturing plants of Nairobi, Kenya. A variety of different paint production jobs were monitored, including laboratory researchers, mixers, tinters, fillers, cleaners, raw materials deliverers, and resins producers. Exposure levels were calculated based on a time-weighted average over an entire 8-10 hour workday. The paint solvents used can cause both acute and chronic health problems for the workers exposed. For example, over half of the organics monitored, i.e. benzene, styrene, and xylene, exhibit carcinogenic properties. The lifetime cancer risk from exposure to these paint solvents was estimated utilizing published cancer potencies, and the risks range from 1.90 x 10(-4) for raw materials deliverers to 2.60 x 10-2 for cleaners. The highest exposure tasks included cleaning the mixing vats and mixing the paint product, ranging from risks of 8.5 x 10(-4) to 2.6 x 10(-2), providing evidence that solvent exposure occurs due to point sources. Because of this, simple and inexpensive technologies should significantly reduce the excess exposure of workers in these manufacturing facilities. The cost of minor-innovations in the plants themselves, such as fans, drum and mixing vat covers, and respirators, could amount to as much as five times less than the estimated cost of treating workers who develop cancer due to paint solvent exposure.


Asunto(s)
Exposición Profesional , Pintura , Solventes/análisis , Análisis Costo-Beneficio , Humanos , Industrias , Kenia , Neoplasias/etiología , Salud Laboral , Compuestos Orgánicos/análisis , Desarrollo de Programa , Medición de Riesgo , Solventes/efectos adversos , Volatilización
9.
Environ Health Perspect ; 108(9): 833-9, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11017887

RESUMEN

Acute and chronic respiratory diseases, which are causally linked to exposure to indoor air pollution in developing countries, are the leading cause of global morbidity and mortality. Efforts to develop effective intervention strategies and detailed quantification of the exposure-response relationship for indoor particulate matter require accurate estimates of exposure. We used continuous monitoring of indoor air pollution and individual time-activity budget data to construct detailed profiles of exposure for 345 individuals in 55 households in rural Kenya. Data for analysis were from two hundred ten 14-hour days of continuous real-time monitoring of concentrations of particulate matter [less than/equal to] 10 microm in aerodynamic diameter and the location and activities of household members. These data were supplemented by data on the spatial dispersion of pollution and from interviews. Young and adult women had not only the highest absolute exposure to particulate matter (2, 795 and 4,898 microg/m(3) average daily exposure concentrations, respectively) but also the largest exposure relative to that of males in the same age group (2.5 and 4.8 times, respectively). Exposure during brief high-intensity emission episodes accounts for 31-61% of the total exposure of household members who take part in cooking and 0-11% for those who do not. Simple models that neglect the spatial distribution of pollution within the home, intense emission episodes, and activity patterns underestimate exposure by 3-71% for different demographic subgroups, resulting in inaccurate and biased estimations. Health and intervention impact studies should therefore consider in detail the critical role of exposure patterns, including the short periods of intense emission, to avoid spurious assessments of risks and benefits.


Asunto(s)
Contaminación del Aire Interior/análisis , Exposición a Riesgos Ambientales/análisis , Vivienda , Adolescente , Adulto , Anciano , Movimientos del Aire , Biomasa , Niño , Culinaria , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tamaño de la Partícula , Medición de Riesgo , Factores Sexuales
10.
Schizophr Bull ; 26(3): 699-708, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10993407

RESUMEN

The Genains, a unique group of monozygotic female quadruplets, all developed a schizophrenic disorder by age 24. They have been studied since the 1950s, because of the rarity of this occurrence (estimated to be one in 1.5 billion) and because their illnesses varied in severity. The identical inheritance would tend to rule out genetic differences as the cause of the neuropsychological differences; however, we cannot disentangle the effects of early brain injury and harsh punitive treatment as factors accounting for the differences in the severity of their disorders. We conducted neuropsychological examinations of the Genains at age 66, compared their test profiles, and contrasted certain test scores at 66 with those at ages 27 and 51. Test results indicate generally stable (or even improved) performance over time and support the notion that cognitive decline is not a degenerative process in schizophrenia. The Genains remind us of the exquisite interaction among variables that must be understood before additional, satisfactory progress can be made in preventing the development and predicting the course of schizophrenia.


Asunto(s)
Cuádruples/psicología , Adulto , Factores de Edad , Envejecimiento , Atención/fisiología , Encéfalo/fisiopatología , Femenino , Estudios de Seguimiento , Estado de Salud , Humanos , Persona de Mediana Edad , Progenie de Nacimiento Múltiple , Pruebas Neuropsicológicas , Esquizofrenia/diagnóstico , Esquizofrenia/fisiopatología , Psicología del Esquizofrénico
11.
Psychiatry Res ; 95(3): 237-43, 2000 Sep 11.
Artículo en Inglés | MEDLINE | ID: mdl-10974362

RESUMEN

The heterogeneity and uncertain significance of neurologic exam abnormalities in schizophrenia prompted us to evaluate their factor structure. We administered a modified version of the Neurological Evaluation Scale (NES) to 103 unmedicated patients with schizophrenia. Data were distilled by combining right- and left-side scores, and by eliminating superfluous, rarely abnormal and unreliable items from the analysis. Exploratory principal components analysis yielded four factors: repetitive motor tasks (fist-ring, fist-edge-palm, alternating fist-palm, dysdiadochokinesis); cognitive-perceptual tasks (memory, audiovisual integration, right-left orientation, face-hand test, rhythm tapping reproduction); balancing tasks (Romberg, tandem gait); and the palmomental reflex. Evaluation of the relationship between these factors and clinical and demographic variables revealed a robust correlation between the cognitive-perceptual factor and full-scale IQ score. This analysis is a step toward developing empirical subscales of a modified NES, which may provide insights into the nature of neurologic impairment in schizophrenia and may prove clinically useful.


Asunto(s)
Examen Neurológico , Esquizofrenia/fisiopatología , Adulto , Enfermedad Crónica , Análisis Factorial , Femenino , Humanos , Masculino
12.
Artículo en Inglés | MEDLINE | ID: mdl-10910089

RESUMEN

OBJECTIVE: The current investigation examines the impact of a past history of alcoholism on neurologic examination abnormalities in schizophrenia (SZ). BACKGROUND: Individuals with SZ have a high rate of comorbid alcohol use disorders (AUDs), but relatively little is known about the potential adverse consequences of alcoholism for neuropsychological and neurologic functioning in SZ. Recent evidence suggests consistent but subtle neurocognitive differences between groups, with more prominent differences in neurologic examination abnormalities. METHOD: Thirty-three male patients with SZ or SZ/AUDs were evaluated using a modified Neurologic Evaluation Scale (NES) and ratings for positive and negative symptoms. RESULTS: The SZ/AUD group exhibited a greater impairment in the Cognitive-Perceptual factor of the Neurologic Evaluation Scale. Greater impairment in the tandem-Romberg factor or in motor items was not found, nor were groups different based on positive or negative symptoms. CONCLUSIONS: A history of alcoholism in SZ is associated with greater overall neurologic impairment, particularly in the area of cognitive-perceptual dysfunction, an area often found to be impaired in patients with schizophrenia without alcoholism.


Asunto(s)
Alcoholismo/psicología , Cognición , Pacientes Internos , Percepción , Esquizofrenia/complicaciones , Psicología del Esquizofrénico , Adulto , Alcoholismo/complicaciones , Alcoholismo/fisiopatología , Análisis de Varianza , Diagnóstico Dual (Psiquiatría) , Análisis Factorial , Humanos , Masculino , Persona de Mediana Edad , Examen Neurológico , Pruebas Neuropsicológicas , Escalas de Valoración Psiquiátrica , Esquizofrenia/fisiopatología
14.
Psychiatry Res ; 93(1): 33-9, 2000 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-10699226

RESUMEN

The aim of the study was to examine effects of haloperidol on the relationships between neuropsychological measures of frontal lobe functioning and the schizophrenia syndromes of psychomotor poverty and disorganization. Twenty-one participants with schizophrenia were initially evaluated when clinically stable and chronically treated with haloperidol, and 19 were evaluated again after a 3-week haloperidol-free period. Participants were evaluated with the Trail Making Test, the Wisconsin Card Sorting Test, the Purdue Pegboard, and psychiatric rating scales at each evaluation. There were significant correlations between schizophrenia syndromes and the tests sensitive to frontal lobe function when participants were medicated but not when drug-free. No significant changes in symptom severity or motor function occurred from the medication to the medication-free evaluation. The results indicate that haloperidol mediates the relationship between tests sensitive to frontal lobe function and the schizophrenia syndromes of psychomotor poverty and disorganization. This mediation effect was not attributable to changes in overall symptom severity or motor function.


Asunto(s)
Antipsicóticos/efectos adversos , Lóbulo Frontal/efectos de los fármacos , Lóbulo Frontal/fisiopatología , Haloperidol/efectos adversos , Desempeño Psicomotor/efectos de los fármacos , Esquizofrenia/tratamiento farmacológico , Esquizofrenia/fisiopatología , Psicología del Esquizofrénico , Adulto , Antipsicóticos/uso terapéutico , Benzotropina/efectos adversos , Estudios Cruzados , Método Doble Ciego , Haloperidol/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Antagonistas Muscarínicos/efectos adversos , Pruebas Neuropsicológicas , Recurrencia , Esquizofrenia/diagnóstico , Síndrome de Abstinencia a Sustancias
15.
Psychiatry Res ; 97(2-3): 137-51, 2000 Dec 27.
Artículo en Inglés | MEDLINE | ID: mdl-11166086

RESUMEN

Albumin and bilirubin are metal-binding proteins, shown to possess free radical scavenging properties, and may thus be selective antioxidants. In the present study we examined whether individual plasma antioxidants such as albumin and bilirubin, which significantly contribute to total antioxidant status (TAS), are reduced in patients with schizophrenia. We prospectively studied plasma antioxidant proteins, i.e. albumin and bilirubin, in male veteran schizophrenic patients using a within-subject, repeated measures, on-off-on haloperidol treatment design, as well as age- and sex-matched healthy volunteers. Male patients with schizophrenia either during haloperidol treatment (n=46) or in a drug-free condition (n=35) had significantly lower levels of both plasma albumin and bilirubin compared with age- and sex-matched healthy volunteers (n=31). Such reductions of plasma antioxidant proteins in schizophrenic patients appear to be age-related changes, in contrast to those observed in healthy volunteers. On the other hand, levels of plasma albumin and bilirubin were not significantly affected by haloperidol treatment, haloperidol withdrawal, or length of drug-free period. Moreover, plasma TAS was not influenced significantly by cigarette smoking, even though it may selectively decrease plasma bilirubin but not albumin levels. The present findings, taken together with our previous results of reduced plasma TAS and uric acid, as well as an increased Red blood cell superoxide dismutase, lend further support to the hypothesis that a defect in the antioxidant defense system exists in schizophrenia that may lead to oxidative damage.


Asunto(s)
Envejecimiento/fisiología , Albúminas/metabolismo , Bilirrubina/sangre , Esquizofrenia/sangre , Adolescente , Adulto , Factores de Edad , Antipsicóticos/uso terapéutico , Ansiedad/sangre , Ansiedad/diagnóstico , Ansiedad/etiología , Depresión/sangre , Depresión/diagnóstico , Depresión/etiología , Haloperidol/uso terapéutico , Humanos , Masculino , Oxidación-Reducción , Estrés Oxidativo/fisiología , Estudios Prospectivos , Trastornos Psicóticos/diagnóstico , Trastornos Psicóticos/etiología , Esquizofrenia/tratamiento farmacológico , Psicología del Esquizofrénico , Índice de Severidad de la Enfermedad
16.
J Expo Anal Environ Epidemiol ; 9(4): 343-51, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10489159

RESUMEN

This paper reports findings from a screening study conducted to examine potential lead (Pb) exposures in residents of a Mexican village where Pb oxide continues to be used in ceramic pottery production. Extremely high Pb concentrations were measured in personal and indoor air samples, household surface dust samples, and household soil samples. Personal air Pb concentrations for workers performing pottery firing and glazing were up to 454 microg/m3. Results from indoor air samples indicate that airborne Pb concentrations were lower during nonglazing period compared to the glazing period. Soil Pb concentrations measured in 17 homes ranged from 0.39 to 19.8 mg/g. Dust Pb loading on surfaces of household items, hands, and clothes of a worker ranged from 172 to 33,060 microg/ft2. Pb content as high as 2.4 microg/g was found in a bean stew cooked in a pot made in the village. Based on these Pb concentrations measured in multiple media and data adapted for exposure contact rates, we have made rough estimates of Pb exposures via inhalation, soil/dust ingestion, and food ingestion. Estimated total daily Pb intake, on average, is 4.0 mg for adults and 3.4 mg for children living in the village. In the total daily intake, a greatest fraction may be contributed by food ingestion and another significant fraction may come from soil/dust ingestion for the children. Although the sample size is small, these measurements indicate a very significant public health problem for the village residents and a large number of other similar communities in Mexico. (It was estimated that there are approximately 1.5 million glaze potters.) The Pb exposure is implicated in a number of pervasive health problems in the region, and is the cause for national and international attention. Several recommended solutions to this problem range from personal protection and behavioral changes to introduction of alternative glazes.


Asunto(s)
Contaminación del Aire Interior/análisis , Cerámica , Polvo/análisis , Exposición a Riesgos Ambientales/análisis , Monitoreo del Ambiente/métodos , Contaminación de Alimentos/análisis , Industrias , Plomo/análisis , Contaminantes del Suelo/análisis , Adulto , Contaminación del Aire Interior/prevención & control , Niño , Culinaria/instrumentación , Culinaria/métodos , Exposición a Riesgos Ambientales/prevención & control , Contaminación de Alimentos/prevención & control , Humanos , Tamizaje Masivo
17.
J Nerv Ment Dis ; 187(7): 414-9, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10426461

RESUMEN

Although numerous studies have consistently revealed cognitive heterogeneity in schizophrenia, the relationships between such heterogeneity and clinical phenomenology are not clear. Clusters derived from cognitive heterogeneity studies may or may not be associated with symptom profile or severity of illness. The purpose of this study was to examine the relationship between cognitive heterogeneity and demographic and clinical phenomenological measures. We examined cognitive heterogeneity in schizophrenia by empirically deriving clusters of patients based upon WAIS-R subtest scores and then analyzed the way in which these clusters related to demographic and symptom variables and to DSM-III-R diagnostic subtypes. Four cognitive clusters were identified that were consistent with previous research. These clusters were differentiated on the basis of educational level and occupational status but not on the basis of symptom profile, severity, or DSM-III-R subtypes. Results suggest that cognitive measures are independent of severity of the disorder and phenomenological symptom presentation in these subgroups of schizophrenic patients.


Asunto(s)
Cognición , Esquizofrenia/diagnóstico , Psicología del Esquizofrénico , Adulto , Algoritmos , Análisis por Conglomerados , Cognición/clasificación , Escolaridad , Humanos , Masculino , Modelos Psicológicos , Ocupaciones , Escalas de Valoración Psiquiátrica/estadística & datos numéricos , Psicometría , Reproducibilidad de los Resultados , Esquizofrenia/clasificación , Índice de Severidad de la Enfermedad , Escalas de Wechsler/estadística & datos numéricos
18.
Biol Psychiatry ; 45(11): 1512-5, 1999 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-10356635

RESUMEN

BACKGROUND: Previous studies have shown impaired antioxidant defense system in schizophrenia, including alterations in glutathione peroxidase (GSH-Px) activity in erythrocytes. There exists a related enzyme, human plasma GSH-Px (hpGSH-Px), that has not been previously examined in schizophrenia. METHODS: An enzyme-linked immunoassay was used to determine hpGSH-Px levels in male schizophrenic patients (n = 39), using a within-subject, on-off haloperidol (HD) treatment design, compared with age- and gender-matched normal control subjects (n = 37). RESULTS: hpGSH-Px was not significantly different between normal control subjects and patients, consistent with our previous findings in erythrocyte GSH-Px. There were no significant treatment effects. hpGSH-Px was significantly and positively correlated with psychosis rating scores in patients both on and off HD treatment. CONCLUSIONS: Although not different from normal controls, hpGSH-Px levels in patients may reflect oxidative stress associated with greater psychosis severity. The present findings thus suggest that schizophrenic patients, without obvious increase of endogenous antioxidant enzymes (e.g., hpGSH-Px), may be at risk for oxidative damage.


Asunto(s)
Glutatión Peroxidasa/sangre , Esquizofrenia/enzimología , Adulto , Antipsicóticos/farmacología , Biomarcadores/sangre , Estudios de Casos y Controles , Enfermedad Crónica , Ensayo de Inmunoadsorción Enzimática , Glutatión Peroxidasa/efectos de los fármacos , Haloperidol/farmacología , Humanos , Masculino , Persona de Mediana Edad , Esquizofrenia/tratamiento farmacológico , Índice de Severidad de la Enfermedad
19.
Biol Psychiatry ; 45(10): 1336-55, 1999 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-10349041

RESUMEN

BACKGROUND: Disturbances in language associations were among the first clinical symptoms reported for individuals described as schizophrenic (Bleuler 1911/1950). Currently, associative language disturbance is a diagnostic feature of schizophrenia (American Psychiatric Association 1994); however, the mechanisms that produce this symptom remain unknown. In the present study, two candidate psychological functions were examined: sensitivity to semantic context and expectancy (attention). METHODS: Visual event-related potentials were recorded during a lexical decision task in which semantic relationship and expectancy (relatedness proportions) were varied. Semantic priming processes were compared between 34 male normal control subjects tested once and 37 male schizophrenic inpatients evaluated during their participation in a double-blind haloperidol maintenance therapy and placebo replacement protocol. RESULTS: Schizophrenic patients failed to discriminate between associated and unassociated words, as measured by the amplitude of the N400 component (i.e., absence of the N400 priming effect); however, the overall mean amplitude of N400 did not differ between patients and control subjects. In addition, patients and control subjects did not differ significantly in the amplitude of N400 elicited to associated words or to unassociated words. Finally, the effect of expectancy-based processing on the magnitude of the N400 priming effect did not differ between patients and control subjects. CONCLUSIONS: On the basis of these findings, a tentative hypothesis is suggested that schizophrenic patients are characterized by a pattern of indiscriminate or random spread of activation in their semantic network during the processing of single-word semantic contexts.


Asunto(s)
Atención/fisiología , Potenciales Evocados/fisiología , Haloperidol/uso terapéutico , Esquizofrenia/diagnóstico , Esquizofrenia/tratamiento farmacológico , Psicología del Esquizofrénico , Semántica , Estimulación Acústica , Adulto , Discriminación en Psicología , Electroencefalografía/estadística & datos numéricos , Potenciales Relacionados con Evento P300/efectos de los fármacos , Potenciales Relacionados con Evento P300/fisiología , Potenciales Evocados/efectos de los fármacos , Haloperidol/farmacología , Humanos , Masculino , Memoria/fisiología , Pruebas de Asociación de Palabras
20.
Neuropsychopharmacology ; 20(6): 603-11, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10327429

RESUMEN

The objective of this study was to determine the association between the patterns of change in the dopaminergic metabolite plasma homovanillic acid (HVA), the noradrenergic metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG), and psychosis following haloperidol withdrawal in schizophrenic patients. Weekly plasma measurements were obtained in 107 subjects with schizophrenia or schizoaffective disorder. Random regression was used to control for individual variance while modeling metabolite changes over time and relationships with psychosis. Changes in plasma MHPG were not significantly associated with relapse or psychosis, while increased plasma HVA was found to be associated with relapse. Psychosis was correlated negatively with plasma HVA levels. The current analysis, controlling for individual variance, indicates that there is evidence for pharmacological effects on plasma HVA, but not plasma MHPG. In addition, these metabolites do not appear to be direct markers of psychosis, but may be associated with a compensatory response by the system to return to the steady state.


Asunto(s)
Antipsicóticos/uso terapéutico , Trastorno Bipolar/sangre , Catecolaminas/sangre , Esquizofrenia/sangre , Adulto , Biomarcadores/sangre , Trastorno Bipolar/etiología , Trastorno Bipolar/metabolismo , Catecolaminas/metabolismo , Ácido Homovanílico/sangre , Humanos , Masculino , Metoxihidroxifenilglicol/sangre , Persona de Mediana Edad , Evaluación de Resultado en la Atención de Salud , Esquizofrenia/complicaciones , Esquizofrenia/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...